Prediction of Non-Alcoholic Fatty Liver Disease (NAFLD) in Both Lean and Obese Patients Utilizing the Waist to Height Ratio (WHR) and Fatty Liver Index (FLI)
Article Sidebar
Main Article Content
Abstract
Background: Non-alcoholic fatty liver disease (NAFLD) is a burgeoning health issue with a global prevalence that mirrors the rise in obesity and metabolic syndrome. Non-invasive diagnostic indices like the Waist to Height Ratio (WHtR) and the Fatty Liver Index (FLI) are crucial for early detection and management, offering an alternative to the invasive liver biopsy. These indices are particularly pertinent for populations with distinctive body compositions, such as those seen in Asian countries, where traditional measures like Body Mass Index (BMI) may not accurately reflect metabolic risk.
Objective: To evaluate the efficacy of WHtR and FLI as non-invasive diagnostic tools for NAFLD in both lean and obese populations, and to identify the most reliable indicator for predicting the presence of fatty liver disease across different body compositions.
Methods: This cross-sectional study was approved by the Ethical Review Board (ERC-771) and conducted at the Sindh Institute of Urology and Transplantation. It included 757 participants aged 18-70 years, with 559 lean and 298 obese individuals based on BMI classifications. Exclusion criteria included other forms of hepatitis, use of steatogenic medication, and significant gastrointestinal disorders. Diagnostic measures included abdominal ultrasonography performed by an expert radiologist and calculation of WHtR and FLI. Statistical analyses were performed using SPSS version 25, and diagnostic accuracy was assessed through sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and Area Under the Receiver Operating Characteristic (AUROC) curves.
Results: Fatty liver was detected in 49% of obese patients and 33% of lean patients. The obese cohort demonstrated a WHtR >0.63 with a diagnostic accuracy of 94.63%, whereas the FLI had a diagnostic accuracy of 83.6% for a cutoff >74. In lean patients, FLI >16.5 was more predictive of NAFLD with a diagnostic accuracy of 96.96%, as opposed to WHtR, which was less effective. The AUROC for WHtR and FLI in obese patients was 0.847 and 0.704, respectively, while in lean patients, the AUROC for FLI was 0.875, suggesting superior diagnostic performance over WHtR.
Conclusion: The study confirms that WHtR and FLI are valuable non-invasive tools for predicting NAFLD, with WHtR being more effective in obese patients and FLI showing greater reliability in lean patients. These findings highlight the need for tailored approaches in diagnosing NAFLD according to body composition. Further large-scale, multicentric research is needed to generalize these diagnostic cut-offs.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Chalasani N, Younossi Z, Lavine JE, et al. The Diagnosis and Management of Non-Alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55:2005-23.
Farrell GC, Wong VW, Chitturi S. NAFLD in Asia as Common and Important as in the West. Nat Rev Gastroenterol Hepatol. 2013;10:307-18.
Younossi ZM, Koenig AB, Abdelatif D, et al. Global Epidemiology of Non-Alcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence and Outcomes. Hepatology. 2016;64:73-84.
LaBrecque DR, Abbas Z, Anania F, et al. World Gastroenterology Organisation Global Guidelines: Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. J Clin Gastroenterol. 2014;48:467-473.
Singh S, Allen AM, Wang Z, et al. Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-Analysis of Paired-Biopsy Studies. Clin Gastroenterol Hepatol. 2015;13:643-654.
Feng RN, Zhao C, Wang C, et al. BMI Is Strongly Associated With Hypertension, and Waist Circumference Is Strongly Associated With Type 2 Diabetes and Dyslipidemia, in Northern Chinese Adults. J Epidemiol. 2012;22:317-323.
Rush E, Plank L, Chandu V, et al. Body Size, Body Composition, and Fat Distribution: A Comparison of Young New Zealand Men of European, Pacific Island, and Asian Indian Ethnicities. N Z Med J. 2004;117:1203.
Deurenberg-Yap M, Chew SK, Deurenberg P. Elevated Body Fat Percentage and Cardiovascular Risks at Low Body Mass Index Levels Among Singaporean Chinese, Malays and Indians. Obes Rev. 2002;3:209-15.
Wang J, Thornton JC, Russell M, et al. Asians Have Lower BMI but Higher Percent Body Fat than Do Whites: Comparisons of Anthropometric Measurements. Am J Clin Nutr. 1994;60:23-8.
Deurenberg-Yap M, Schmidt G, Staveren van WA, et al. The Paradox of Low Body Mass Index and High Body Fat Percent Among Chinese, Malays and Indians in Singapore. Int J Obes Relat Metab Disord. 2000;24:1011-7.
Sanyal AJ. The Metabolic Abnormalities Associated With Non-Alcoholic Fatty Liver Disease. Best Pract Res Clin Gastroenterol. 2002;16:709-731.
Ashwell M, Cole TJ, Dixon AK. Ratio of Waist Circumference to Height Is a Strong Predictor of Intra-Abdominal Fat. BMJ. 1996;313:559-60.
Ashwell M, Gunn P, Gibson S. Waist-to-Height Ratio Is a Better Screening Tool Than Waist Circumference and BMI for Adult Cardiometabolic Risk Factors: Systematic Review and Meta-Analysis. Obes Rev. 2012;13:275-86.
Motamed N, Rabiee B, Hemasi GR, et al. Body Roundness Index and Waist-to-Height Ratio Are Strongly Associated With Non-Alcoholic Fatty Liver Disease: A Population-Based Study. Hepat Mon. 2016;16:39575.
Bedogni G, Bellentani S, Miglioli L, et al. The Fatty Liver Index: A Simple and Accurate Predictor of Hepatic Steatosis in the General Population. BMC Gastroenterol. 2006;6:33.
Li C, Guo P, Zhang R, et al. Both WHR and FLI as Better Algorithms for Both Lean and Overweight/Obese NAFLD in a Chinese Population. J Clin Gastroenterol. 2019;53:253-260.
Khan RTY, Hussain SZ, Shahzad S, et al. Frequency of Non-Alcoholic Fatty Liver Disease Among the Non-Obese Population Presenting to the Gastrointestinal Outpatient Clinic. J Liaquat Natl Hosp. 2024;1:117-121.
Long MT, Gandhi S, Loomba R. Advances in Non-Invasive Biomarkers for the Diagnosis and Monitoring of Non-Alcoholic Fatty Liver Disease. Metabolism. 2020;111:154259.
Patel AH, Peddu D, Amin S, et al. Nonalcoholic Fatty Liver Disease in Lean/Nonobese and Obese Individuals: A Comprehensive Review on Prevalence, Pathogenesis, Clinical Outcomes, and Treatment. J Clin Transl Hepatol. 2023;28:502-515.
Deurenberg P, Deurenberg-Yap M, Guricci S. Asians Are Different From Caucasians and From Each Other in Their Body Mass Index/Body Fat Per Cent Relationship. Obes Rev. 2002;3:141-6.
Du T, Sun X, Yin P, et al. Increasing Trends in Central Obesity Among Chinese Adults With Normal Body Mass Index, 1993-2009. BMC Public Health. 2013;13:327.
Cusi K. Role of Insulin Resistance and Lipotoxicity in Non-Alcoholic Steatohepatitis. Clin Liver Dis. 2009;13:545-63.
Verna EC, Berk PD. Role of Fatty Acids in the Pathogenesis of Obesity and Fatty Liver: Impact of Bariatric Surgery. Semin Liver Dis. 2008;28:407-426.
Bi WR, Yang CQ, Shi Q, et al. Large-Scale Analysis of Factors Influencing Nonalcoholic Fatty Liver Disease and Its Relationship With Liver Enzymes. Genet Mol Res. 2014;13:5880-91.
Arteaga I, Buezo I, Exposito C, et al. Non-Invasive Markers of Fibrosis in the Diagnosis of Non-Alcoholic Fatty Liver Disease. Gastroenterol Hepatol. 2014;37:503-10.
Koehler EM, Schouten JN, Hansen BE, et al. External Validation of the Fatty Liver Index for Identifying Nonalcoholic Fatty Liver Disease in a Population-Based Study. Clin Gastroenterol Hepatol. 2013;11:1201-4.
Hsu CL, Wu FZ, et al. Role of Fatty Liver Index and Metabolic Factors in the Prediction of Nonalcoholic Fatty Liver Disease in a Lean Population Receiving Health Checkup. [Journal Article]. Year;Volume(Issue):Page-Page